Provide resources to families affected by childhood Leukemia; Provide resources for research-intensive purposes; Host workshops and information sessions.
DEUCES TO LEUKEMA is a based in ROWLETT, TX, focused on Philanthropy, Voluntarism and Grantmaking Foundations causes , specifically Community Foundations. Established in August 2019, it operates as an independent corporation and contributions to this organization are tax-deductible .
With total assets of $0.00, this ranks 2,541,236 among 2,656,690 nonprofits nationally (Top 96%), demonstrating developing financial capacity relative to its peers. At the state level, it stands at 200,830 out of 202,022 organizations in TX (Top 100%).
In dallas county, TX, the organization ranks 23,850 out of 26,443 nonprofits by assets (Top 91%), while locally in rowlett, it stands at 321 among 429 organizations (Top 73%).
The organization reported no revenue in the most recent filing period, placing it at 2,006,480 nationally and 162,329 in TX.
Within its specific NTEE classification (T31 - T: Philanthropy, Voluntarism and Grantmaking Foundations), which includes 4,422 similar organizations, DEUCES TO LEUKEMA ranks 3,947 in assets (Top 90%) and 3,730 in revenue (Top 85%).
Note: This organization's tax-exempt status was temporarily revoked on November 15, 2022 .
The organization files a 990 - Required to file Form 990-N - Income less than $25,000 per year and operates on a May fiscal year.
IRS STATEMENT:
"Important note: Just because an organization appears on this list, it does not
mean the organization is currently revoked, as they may have been reinstated."
You may confirm an organization's status by calling the IRS (toll-free) at 1-877-829-5500.
Disclaimer: While we are confident of the accuracy of the information on this page, we encourage you verify the information directly with IRS. The IRS has a toll-free number for this at 1-877-829-5500 or visit www.irs.gov.
Login to:
Register to:
Use the link provided to create your password, log in, and gain access to the 501c3 Lookup platform.